AI assistant
Sending…
UNIVERSAL HEALTH SERVICES INC — Director's Dealing 2012
Dec 14, 2012
30533_dirs_2012-12-14_4f00a045-b172-45fc-b0ed-dd4cccd66143.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: UNIVERSAL HEALTH SERVICES INC (UHS)
CIK: 0000352915
Period of Report: 2012-12-13
Reporting Person: MILLER ALAN B (Director, Chairman and CEO, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-12-13 | Class B Common Stock | S | 5000 | $45.9624 | Disposed | 428143 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Class B Common Stock | 16615 | Indirect |
| Class B Common Stock | 59900 | Indirect |
| Class B Common Stock | 100000 | Indirect |
| Class B Common Stock | 16615 | Indirect |
| Class B Common Stock | 100000 | Indirect |
| Class B Common Stock | 16615 | Indirect |
| Class B Common Stock | 100000 | Indirect |
| Class B Common Stock | 24708 | Indirect |
| Class B Common Stock | 59900 | Indirect |
| Class B Common Stock | 59900 | Indirect |
Footnotes
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.900 to $46.050, inclusive. The reporting person undertakes to provide to Universal Health Services, Inc. (the "Company"), any stockholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote 1.
More from UNIVERSAL HEALTH SERVICES INC
Declaration of Voting Results & Voting Rights Announcements
2026
May 22
Board/Management Information
2026
May 21
Interim / Quarterly Report
2026
May 7
Major Shareholding Notification
2026
Apr 30
Regulatory Filings
2026
Apr 28
Capital/Financing Update
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 9
Annual Report
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Regulatory Filings
2026
Mar 30